Skip to content
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Contact Us
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Contact Us
Search
Back to News
May 26, 2016
Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study
Prev
Previous
Endologix Completes Patient Enrollment in the Ovation® LIFE (Least Invasive Fast-Track EVAR) Study
Next
Endologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy
Next